National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch
National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch
Bethesda, Maryland, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCD Stem Cell Mobilization and Apheresis Using Motixafortide | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 1 | 2026-09-08 | NCT06442761 |